Smart Inhalers - Global Market Outlook (2016-2022)

September 2016 | 121 pages | ID: S7DA563BBB5EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Smart Inhalers market is accounted for $5.8 million in 2015 and is expected to reach $198 million by 2022 growing at a CAGR of 65.5% from 2015 to 2022. Increasing respiratory disorders, rise in air pollution, improved adherence to the inhaler are some of the factors boosting the market growth. However, lesser availability of smart inhalers, high expenditure of asthma and COPD treatment, and resistance towards adoption of smart inhalers are hindering the market growth.

North America is projected to be the leading revenue generating region, whereas Asia-Pacific is projected to grow at the highest rate, due to rise in demand for smart inhalers and increase in COPD and asthma instances.

Some of the key players in global Smart Inhalers market are Propeller Health, Glenmark Pharmaceuticals, Qualcomm Life, Opko Health, Adherium Limited, GlaxoSmithKline plc, Novartis AG, AstraZeneca plc , Boehringer Ingelheim GmbH, 3M Drug Delivery Systems, Sensirion AG, Novartis AG, CoheroHealth, Crux Product Design Ltd, e-pill, LLC, Vectura Group plc, Teva Pharmaceutical Industries Ltd., OMRON Healthcare Europe B.V, Shenzhen Bi-Rich Medical Devices Co., Ltd, Inspiro Medical Ltd, TRI-MED, INC., PARI GmbH and Philips Respironics.

Products Covered:

• Inhalers
• Nebulizers
• Smater Dry Powder Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)

Disorders Covered:

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

End Users Covered:

• Patients
• Research & Development

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging markets
3.7 Product Analysis
3.8 End User Analysis

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL SMART INHALERS MARKET, BY PRODUCT

5.1 Introduction
5.2 Inhalers
5.3 Nebulizers
5.4 Smater Dry Powder Inhalers (DPIs)
5.5 Metered Dose Inhalers (MDIs)

6 GLOBAL SMART INHALERS MARKET, BY DISORDER

6.1 Introduction
6.2 Asthma
6.3 Chronic Obstructive Pulmonary Disease (COPD)

7 GLOBAL SMART INHALERS MARKET, BY END USER

7.1 Introduction
7.2 Patients
7.3 Research & Development

8 GLOBAL SMART INHALERS MARKET, BY GEOGRAPHY

8.1 North America
  8.1.1 US
  8.1.2 Canada
  8.1.3 Mexico
8.2 Europe
  8.2.1 Germany
  8.2.2 France
  8.2.3 Italy
  8.2.4 UK
  8.2.5 Spain
  8.2.8 Rest of Europe
8.3 Asia Pacific
  8.3.1 Japan
  8.3.2 China
  8.3.3 India
  8.3.4 Australia
  8.3.5 New Zealand
  8.3.8 Rest of Asia Pacific
8.4 Rest of the World
  8.4.1 Middle East
  8.4.2 Brazil
  8.4.3 Argentina
  8.4.4 South Africa
  8.4.5 Egypt

9 KEY DEVELOPMENTS

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING

10.1 Propeller Health
10.2 Glenmark Pharmaceuticals
10.3 Qualcomm Life
10.4 Opko Health
10.5 Adherium Limited
10.6 GlaxoSmithKline plc
10.7 Novartis AG
10.8 AstraZeneca plc
10.9 Boehringer Ingelheim GmbH
10.10 3M Drug Delivery Systems
10.11 Sensirion AG
10.12 Novartis AG
10.13 CoheroHealth
10.14 Crux Product Design Ltd
10.15 e-pill, LLC
10.16 Vectura Group plc
10.17 Teva Pharmaceutical Industries Ltd.
10.18 OMRON Healthcare Europe B.V
10.19 Shenzhen Bi-Rich Medical Devices Co., Ltd
10.20 Inspiro Medical Ltd
10.21 TRI-MED, INC.
10.22 PARI GmbH
10.23 Philips Respironics

List Of Tables

LIST OF TABLES

1 Global Smart Inhalers Market Analysis, by Region, (2013-2022) ($MN)
2 Global Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN)
3 Global Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN)
4 Global Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
5 Global Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
6 Global Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
7 Global Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN)
8 Global Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN)
9 Global Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
10 Global Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN)
11 Global Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN)
12 Global Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
13 North America Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN)
14 North America Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN)
15 North America Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN)
16 North America Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
17 North America Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
18 North America Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
19 North America Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN)
20 North America Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN)
21 North America Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
22 North America Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN)
23 North America Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN)
24 North America Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
25 Europe Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN)
26 Europe Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN)
27 Europe Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN)
28 Europe Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
29 Europe Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
30 Europe Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
31 Europe Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN)
32 Europe Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN)
33 Europe Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
34 Europe Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN)
35 Europe Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN)
36 Europe Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
37 Asia Pacific Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN)
38 Asia Pacific Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN)
39 Asia Pacific Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN)
40 Asia Pacific Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
41 Asia Pacific Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
42 Asia Pacific Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
43 Asia Pacific Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN)
44 Asia Pacific Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN)
45 Asia Pacific Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
46 Asia Pacific Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN)
47 Asia Pacific Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN)
48 Asia Pacific Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)
49 RoW Smart Inhalers Market Analysis, by Country, (2013-2022) ($MN)
50 RoW Smart Inhalers Market Analysis, by Product, (2013-2022) ($MN)
51 RoW Smart Inhalers Market Analysis, by Inhalers, (2013-2022) ($MN)
52 RoW Smart Inhalers Market Analysis, by Nebulizers, (2013-2022) ($MN)
53 RoW Smart Inhalers Market Analysis, by Smater Dry Powder Inhalers (DPIs), (2013-2022) ($MN)
54 RoW Smart Inhalers Market Analysis, by Metered Dose Inhalers (MDIs), (2013-2022) ($MN)
55 RoW Smart Inhalers Market Analysis, by Disorder, (2013-2022) ($MN)
56 RoW Smart Inhalers Market Analysis, by Asthma , (2013-2022) ($MN)
57 RoW Smart Inhalers Market Analysis, by Chronic Obstructive Pulmonary Disease (COPD), (2013-2022) ($MN)
58 RoW Smart Inhalers Market Analysis, by End User, (2013-2022) ($MN)
59 RoW Smart Inhalers Market Analysis, by Patients , (2013-2022) ($MN)
60 RoW Smart Inhalers Market Analysis, by Research & Development, (2013-2022) ($MN)